Fibrin-Heparin-Coated Intracranial Stents as Salvage Therapy in Pediatric Focal Cerebral Arteriopathy-Inflammatory Type.

AJNR Am J NeuroradiolOct 1, 2026 (epub)

Marija Cagalj, Anna Schaper, Christian Brickmann et al.

✦ AI-curated · Sources linked

Case in brief

A 13-year-old boy presented with progressive arterial ischemic stroke due to focal cerebral arteriopathy inflammatory type. Initial treatments, including antiplatelet and immunosuppressive therapies, failed to prevent clinical and radiographic deterioration. Successful revascularization was achieved through endovascular therapy using balloon angioplasty and fibrin-heparin-coated intracranial stents, leading to stabilization, although he continued to experience hemiparesis.

Diagnostic / clinical pearl

In cases of pediatric arterial ischemic stroke, consider focal cerebral arteriopathy inflammatory type, especially when initial medical therapies are ineffective.

Why it matters

This case highlights the potential role of fibrin-heparin-coated stents in managing complex pediatric cerebrovascular conditions that do not respond to conventional treatments.

Source

Published in AJNR Am J Neuroradiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.